Sirtuin 3 inhibits hepatocellular carcinoma growth through the glycogen synthase kinase-3β/BCL2-associated X protein-dependent apoptotic pathway.
about
Sirtuin 3 enhanced drug sensitivity of human hepatoma cells through glutathione S-transferase pi 1/JNK signaling pathwayMitochondrial Sirtuins in Cancer: Emerging Roles and Therapeutic Potential.Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma.Glycogen synthase kinase-3β inhibition promotes lysosome-dependent degradation of c-FLIPL in hepatocellular carcinoma.SIRT6 Depletion Sensitizes Human Hepatoma Cells to Chemotherapeutics by Downregulating MDR1 Expression.Prognostic and clinicopathological value of SIRT3 expression in various cancers: a systematic review and meta-analysis.
P2860
Sirtuin 3 inhibits hepatocellular carcinoma growth through the glycogen synthase kinase-3β/BCL2-associated X protein-dependent apoptotic pathway.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Sirtuin 3 inhibits hepatocellu ...... n-dependent apoptotic pathway.
@en
type
label
Sirtuin 3 inhibits hepatocellu ...... n-dependent apoptotic pathway.
@en
prefLabel
Sirtuin 3 inhibits hepatocellu ...... n-dependent apoptotic pathway.
@en
P2093
P2860
P356
P1433
P1476
Sirtuin 3 inhibits hepatocellu ...... n-dependent apoptotic pathway.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2015.121
P407
P577
2015-04-27T00:00:00Z
P6179
1019110731